2013•Practical Preventive MedicineRequires access

Expression and Clinical Significance of Matrix Metalloproteinase-13 and Tissue Inhibitor of Matrix Metalloproteinases-3 Protein in Uterine Leiomyoma

Ling Shi

Open publisher page 0 citations

Abstract

Objective To observe the expression of matrix metalloproteinase 13(MMP-13) and tissue inhibitor of matrix metalloproteinases 3(TIMP-3) in uterine leiomyoma,and to explore the relationship among MMP-13,TIMP-3 and the incidence of uterine leiomyoma as well as their clinical significance.Methods Immunohistochemical SP method was used to detect the expression of MMP-13 and TIMP-3 protein in 57 cases of uterine leiomyoma and 45 cases of uterine fibroids and peritumoral tissues,and the results were compared.Results MMP-13 and TIMP-3 were mostly positively expressed in uterine leiomyoma tissues,but mostly negatively expressed in uterine fibroids and peritumoral tissues,and the differences were statistically significant(P0.05).Conclusions The abnormal expression of MMP-13 and TIMP-3 in uterine tissue may be associated with the incidence of uterine leiomyoma.

About this research paper

What this paper is about

Objective To observe the expression of matrix metalloproteinase 13(MMP-13) and tissue inhibitor of matrix metalloproteinases 3(TIMP-3) in uterine leiomyoma,and to explore the relationship among MMP-13,TIMP-3 and the incidence of uterine leiomyoma as well as their clinical significance.Methods Immunohistochemical SP method was used to detect the expression of MMP-13 and TIMP-3 protein in 57 cases of uterine leiomyoma and 45 cases of uterine fibroids and peritumoral tissues,and the results were compared.Results MMP-13 and TIMP-3 were mostly positively expressed in uterine leiomyoma tissues,but mostly negatively expressed in uterine fibroids and peritumoral tissues,and the differences were statistically significant(P0.05).Conclusions The abnormal expression of MMP-13 and TIMP-3 in uterine tissue may be associated with the incidence of uterine leiomyoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the expression of matrix metalloproteinase 13(MMP-13) and tissue inhibitor of matrix metalloproteinases 3(TIMP-3) in uterine leiomyoma,and to explore the relationship among MMP-13,TIMP-3 and the incidence of uterine leiomyoma as well as their clinical significance.Methods Immunohistochemical SP method was used to detect the expression of MMP-13 and TIMP-3 protein in 57 cases of uterine leiomyoma and 45 cases of uterine fibroids and peritumoral tissues,and the results were compared.Results MMP-13 and TIMP-3 were mostly positively expressed in uterine leiomyoma tissues,but mostly negatively expressed in uterine fibroids and peritumoral tissues,and the differences were statistically significant(P0.05).Conclusions The abnormal expression of MMP-13 and TIMP-3 in uterine tissue may be associated with the incidence of uterine leiomyoma.

Key concepts: Matrix metalloproteinase, Uterine leiomyoma, Leiomyoma, Uterine fibroids, Immunohistochemistry, Clinical significance, Medicine, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and Clinical Significance of Matrix Metalloproteinase-13 and Tissue Inhibitor of Matrix Metalloproteinases-3 Protein in Uterine Leiomyoma — Research Paper | ScholarLens